{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:56:36Z","timestamp":1767084996417,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,30]]},"DOI":"10.7759\/cureus.100388","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:46:21Z","timestamp":1767084381000},"source":"Crossref","is-referenced-by-count":0,"title":["Myopathies Associated With Monoclonal Gammopathies of Clinical Significance: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Mohamed Reda","family":"Belkhribchia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.914379","article-title":"Case report: monoclonal gammopathies of clinical significance-associated myopathy: a case-based review","volume":"12","author":"Yu H","year":"2022","unstructured":"Yu H, He D, Zhang Q, Cao B, Liu W, Wu Y. Case report: monoclonal gammopathies of clinical significance-associated myopathy: a case-based review. Front Oncol. 2022, 12:914379. 10.3389\/fonc.2022.914379","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12890\/2020_002095","article-title":"Skeletal myopathy as the initial manifestation of light chain multiple myeloma","volume":"7","author":"Belkhribchia MR","year":"2020","unstructured":"Belkhribchia MR, Moukhlis S, Bentaoune T, Chourkani N, Zaidani M, Karkouri M. Skeletal myopathy as the initial manifestation of light chain multiple myeloma. Eur J Case Rep Intern Med. 2020, 7:002095. 10.12890\/2020_002095","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23287","article-title":"Expanding the spectrum of monoclonal light chain deposition disease in muscle","volume":"45","author":"Ostrow LW","year":"2012","unstructured":"Ostrow LW, Corse AM, Morrison BM, Huff CA, Carrino JA, Hoke A, Mammen AL. Expanding the spectrum of monoclonal light chain deposition disease in muscle. Muscle Nerve. 2012, 45:755-61. 10.1002\/mus.23287","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.216","article-title":"An autopsy case of light chain deposition disease","volume":"33","author":"Kasahara N","year":"1994","unstructured":"Kasahara N, Tamura H, Matsumura O, et al.. An autopsy case of light chain deposition disease. Intern Med. 1994, 33:216-21. 10.2169\/internalmedicine.33.216","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180362.90078.dc","article-title":"Sporadic late onset nemaline myopathy","volume":"65","author":"Chahin N","year":"2005","unstructured":"Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005, 65:1158-64. 10.1212\/01.wnl.0000180362.90078.dc","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007777","article-title":"Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes","volume":"93","author":"Naddaf E","year":"2019","unstructured":"Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology. 2019, 93:e298-305. 10.1212\/WNL.0000000000007777","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2019.06.038","article-title":"P.09Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMGS)","volume":"29","author":"Allenbach Y","year":"2019","unstructured":"Allenbach Y, Salort-Campana E, Malfatti E, et al.. P.09Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMGS). Neuromuscul Disord. 2019, 29:44.","journal-title":"Neuromuscul Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16008","article-title":"Treatment-responsive glycogen storage myopathy in a patient with POEMS syndrome: a new monoclonal gammopathy-associated myopathy","volume":"30","author":"Soontrapa P","year":"2023","unstructured":"Soontrapa P, Tracy JA, Gonsalves WI, Liewluck T. Treatment-responsive glycogen storage myopathy in a patient with POEMS syndrome: a new monoclonal gammopathy-associated myopathy. Eur J Neurol. 2023, 30:3404-6. 10.1111\/ene.16008","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70026","article-title":"Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS)","volume":"32","author":"Staedler K","year":"2025","unstructured":"Staedler K, Allenbach Y, Salort-Campana E, et al.. Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS). Eur J Neurol. 2025, 32:e70026. 10.1111\/ene.70026","journal-title":"Eur J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91393","article-title":"Monoclonal gammopathy of clinical significance-associated glycogen storage myopathy: a novel acquired muscle disease","volume":"17","author":"Belkhribchia MR","year":"2025","unstructured":"Belkhribchia MR, Toua T, Lobrinus JA, Vallat JM, Salmaoui J. Monoclonal gammopathy of clinical significance-associated glycogen storage myopathy: a novel acquired muscle disease. Cureus. 2025, 17:e91393. 10.7759\/cureus.91393","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215247","article-title":"Monoclonal gammopathies of clinical significance: a critical appraisal","volume":"14","author":"R\u00edos-Tamayo R","year":"2022","unstructured":"R\u00edos-Tamayo R, Paiva B, Lahuerta JJ, L\u00f3pez JM, Duarte RF. Monoclonal gammopathies of clinical significance: a critical appraisal. Cancers (Basel). 2022, 14:5247. 10.3390\/cancers14215247","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand JP","year":"2018","unstructured":"Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 2018, 132:1478-85. 10.1182\/blood-2018-04-839480","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001047","article-title":"Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT","volume":"83","author":"Voermans NC","year":"2014","unstructured":"Voermans NC, Benveniste O, Minnema MC, et al.. Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology. 2014, 83:2133-9. 10.1212\/WNL.0000000000001047","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23954","article-title":"Sporadic late onset nemaline myopathy and immunoglobulin deposition disease","volume":"48","author":"Doppler K","year":"2013","unstructured":"Doppler K, Knop S, Einsele H, Sommer C, Wessig C. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease. Muscle Nerve. 2013, 48:983-8. 10.1002\/mus.23954","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.06.027","article-title":"Systemic immunoglobulin light chain amyloidosis-associated myopathy: presentation, diagnostic pitfalls, and outcome","volume":"91","author":"Muchtar E","year":"2016","unstructured":"Muchtar E, Derudas D, Mauermann M, et al.. Systemic immunoglobulin light chain amyloidosis-associated myopathy: presentation, diagnostic pitfalls, and outcome. Mayo Clin Proc. 2016, 91:1354-61. 10.1016\/j.mayocp.2016.06.027","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39576","article-title":"Amyloid myopathy: a cunning masquerader","volume":"15","author":"Parthiban GP","year":"2023","unstructured":"Parthiban GP, Wilson J, Nesheiwat J. Amyloid myopathy: a cunning masquerader. Cureus. 2023, 15:e39576. 10.7759\/cureus.39576","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF00190993","article-title":"MRI evaluation of amyloid myopathy","volume":"21","author":"Metzler JP","year":"1992","unstructured":"Metzler JP, Fleckenstein JL, White CL 3rd, Haller RG, Frenkel EP, Greenlee RG Jr. MRI evaluation of amyloid myopathy. Skeletal Radiol. 1992, 21:463-5. 10.1007\/BF00190993","journal-title":"Skeletal Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2012.01419.x","article-title":"Light chain deposition disease: novel biological insights and treatment advances","volume":"34","author":"Jimenez-Zepeda VH","year":"2012","unstructured":"Jimenez-Zepeda VH. Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol. 2012, 34:347-55. 10.1111\/j.1751-553X.2012.01419.x","journal-title":"Int J Lab Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.84.14_supplement.P5.056","article-title":"The neuromuscular features of light chain deposition disease (P5.056)","volume":"84","author":"Zhang L","year":"2015","unstructured":"Zhang L, Ferrante M, Ly H, Bertorini T. The neuromuscular features of light chain deposition disease (P5.056). Neurol. 2015, 84:P5.056. 10.1212\/WNL.84.14_supplement.P5.056","journal-title":"Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8588(05)70123-4","article-title":"Nonamyloidotic monoclonal immunoglobulin deposition disease: light-chain, heavy-chain, and light- and heavy-chain deposition diseases","volume":"13","author":"Buxbaum J","year":"1999","unstructured":"Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease: light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am. 1999, 13:1235-48. 10.1016\/s0889-8588(05)70123-4","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14740\/jh1038","article-title":"Treatment of light chain deposition disease: a systematic review","volume":"11","author":"Masood A","year":"2022","unstructured":"Masood A, Ehsan H, Iqbal Q, Salman A, Hashmi H. Treatment of light chain deposition disease: a systematic review. J Hematol. 2022, 11:123-30. 10.14740\/jh1038","journal-title":"J Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed RH","year":"2015","unstructured":"Sayed RH, Wechalekar AD, Gilbertson JA, et al.. Natural history and outcome of light chain deposition disease. Blood. 2015, 126:2805-10. 10.1182\/blood-2015-07-658872","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.132","article-title":"Adult-onset nemaline myopathy and monoclonal gammopathy","volume":"63","author":"Keller CE","year":"2006","unstructured":"Keller CE, Hays AP, Rowland LP, Moghadaszadeh B, Beggs AH, Bhagat G. Adult-onset nemaline myopathy and monoclonal gammopathy. Arch Neurol. 2006, 63:132-4. 10.1001\/archneur.63.1.132","journal-title":"Arch Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000477","article-title":"Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance","volume":"30","author":"Uruha A","year":"2017","unstructured":"Uruha A, Benveniste O. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. Curr Opin Neurol. 2017, 30:457-63. 10.1097\/WCO.0000000000000477","journal-title":"Curr Opin Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2016.10.002","article-title":"Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: first Moroccan experience","volume":"46","author":"Belkhribchia MR","year":"2017","unstructured":"Belkhribchia MR, Tazi I, Louhab N, Kissani N, Mahmal L, Pereon Y. Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: first Moroccan experience. Presse Med. 2017, 46:122-5. 10.1016\/j.lpm.2016.10.002","journal-title":"Presse Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa480","article-title":"Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure","volume":"5","author":"Turnquist C","year":"2021","unstructured":"Turnquist C, Grogono JC, Hofer M, Pitcher A. Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure. Eur Heart J Case Rep. 2021, 5:ytaa480. 10.1093\/ehjcr\/ytaa480","journal-title":"Eur Heart J Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8741-y","article-title":"Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort","volume":"265","author":"Monforte M","year":"2018","unstructured":"Monforte M, Primiano G, Silvestri G, et al.. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort. J Neurol. 2018, 265:542-51. 10.1007\/s00415-018-8741-y","journal-title":"J Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.18071","article-title":"Sporadic late onset nemaline myopathy (SLONM) in an adult presenting with progressive muscle weakness","volume":"6","author":"Paramalingam S","year":"2019","unstructured":"Paramalingam S, Dyke JM, Nossent JC. Sporadic late onset nemaline myopathy (SLONM) in an adult presenting with progressive muscle weakness. Eur J Rheumatol. 2019, 6:105-7. 10.5152\/eurjrheum.2018.18071","journal-title":"Eur J Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103960","article-title":"Sporadic late-onset nemaline myopathy (SLONM): data from a case series and literature review of 144 patients","author":"Lauletta A","year":"2025","unstructured":"Lauletta A, Forcina F, Merlonghi G, et al.. Sporadic late-onset nemaline myopathy (SLONM): data from a case series and literature review of 144 patients. Autoimmun Rev. 2025, 103960. 10.1016\/j.autrev.2025.103960","journal-title":"Autoimmun Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33483","article-title":"Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein","volume":"148","author":"Kotchetkov R","year":"2021","unstructured":"Kotchetkov R, Susman D, Bhutani D, Broch K, Dispenzieri A, Buadi FK. Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein. Int J Cancer. 2021, 148:2807-14. 10.1002\/ijc.33483","journal-title":"Int J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437622-myopathies-associated-with-monoclonal-gammopathies-of-clinical-significance-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:46:23Z","timestamp":1767084383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437622-myopathies-associated-with-monoclonal-gammopathies-of-clinical-significance-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.100388","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}